Harvard, Kesselheim paper highlights almost 90x increase in launch prices for new drugs since 2008
With increasing clamor over rising prices and corresponding inaccessibility of certain drugs, the newest paper out of the Journal of the American Medical Association confirms price increases — and serves as a reminder of a time when the increases weren’t so steep.
The paper, “Trends in Prescription Drug Launch Prices, 2008-2021” was written by Harvard Medical School professors Aaron Kesselheim and Ben Rome, alongside research assistant Alexander Egilman. They found that the mean net price of approved drugs increased by more than 10% every year, and the launch price for new drugs increased exponentially over that same timeframe.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
